ArticleTherapeutics and clinical risk management2016

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.

Koji Ishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.